Shanghai MicroPort MedBot (Group) Co., Ltd. (HKG:2252)
29.26
+2.80 (10.58%)
Sep 8, 2025, 4:08 PM HKT
HKG:2252 Revenue
Shanghai MicroPort MedBot (Group) had revenue of 175.69M CNY in the half year ending June 30, 2025, with 269.07% growth. This brings the company's revenue in the last twelve months to 333.70M, up 113.60% year-over-year. In the year 2024, Shanghai MicroPort MedBot (Group) had annual revenue of 257.25M with 145.95% growth.
Revenue (ttm)
333.70M CNY
Revenue Growth
+113.60%
P/S Ratio
74.63
Revenue / Employee
753.28K CNY
Employees
443
Market Cap
27.29B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 257.25M | 152.66M | 145.95% |
Dec 31, 2023 | 104.59M | 82.99M | 384.15% |
Dec 31, 2022 | 21.60M | 19.45M | 904.79% |
Dec 31, 2021 | 2.15M | - | - |
Dec 31, 2020 | - | - | - |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
BeOne Medicines AG | 35.81B |
Hansoh Pharmaceutical Group Company | 14.45B |
JD Health International | 71.34B |
Innovent Biologics | 12.52B |
Sino Biopharmaceutical | 33.49B |
WuXi Biologics | 21.98B |
Akeso | 2.75B |
CSPC Pharmaceutical Group | 28.49B |